Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effect of deep brain stimulation on quality of life in movement disorders.

Literature DB >> 16107348

The effect of deep brain stimulation on quality of life in movement disorders.

Abstract

Deep brain stimulation (DBS) is a viable treatment alternative for patients with Parkinson's disease (PD), essential tremor (ET), dystonia, and cerebellar outflow tremors. When poorly controlled, these disorders have detrimental effects on the patient's health related quality of life (HRQoL). Instruments that measure HRQoL are useful tools to assess burden of disease and the impact of therapeutic interventions on activities of daily living, employment, and other functions. We systematically and critically reviewed the literature on the effects of DBS on HRQoL in PD, ET, dystonia, and cerebellar outflow tremor related to multiple sclerosis.

Entities: Disease Species

Mesh：

Year: 2005 PMID： 16107348 PMCID： PMC1739801 DOI： 10.1136/jnnp.2005.065334

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

74 in total

1. Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor.

Authors: G-M Hariz; M Lindberg; A T Bergenheim
Journal: J Neurol Neurosurg Psychiatry Date: 2002-01 Impact factor: 10.154

2. Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments.

Authors: J Marinus; C Ramaker; J J van Hilten; A M Stiggelbout
Journal: J Neurol Neurosurg Psychiatry Date: 2002-02 Impact factor: 10.154

3. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

Authors: M P Amato; G Ponziani; F Rossi; C L Liedl; C Stefanile; L Rossi
Journal: Mult Scler Date: 2001-10 Impact factor: 6.312

4. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures.

Authors: J Matsumoto; D Morrow; K Kaufman; D Davis; J E Ahlskog; A Walker; D Sneve; J Noseworthy; M Rodriguez
Journal: Neurology Date: 2001-11-27 Impact factor: 9.910

5. Deep brain stimulation in the treatment of severe dystonia.

Authors: L Vercueil; P Pollak; V Fraix; E Caputo; E Moro; A Benazzouz; J Xie; A Koudsie; A L Benabid
Journal: J Neurol Date: 2001-08 Impact factor: 4.849

6. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up.

Authors: S P Woods; J A Fields; K E Lyons; W C Koller; S B Wilkinson; R Pahwa; A I Tröster
Journal: Acta Neurochir (Wien) Date: 2001-12 Impact factor: 2.216

7. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease.

Authors: Pablo Martínez-Martín; Francesc Valldeoriola; Eduardo Tolosa; Manuela Pilleri; José Luis Molinuevo; Jordi Rumià; Enric Ferrer
Journal: Mov Disord Date: 2002-03 Impact factor: 10.338

8. Quality of life outcomes following surgical treatment of Parkinson's disease.

Authors: Alastair Gray; Iain McNamara; Tipu Aziz; Ralph Gregory; Peter Bain; Joanna Wilson; Richard Scott
Journal: Mov Disord Date: 2002-01 Impact factor: 10.338

9. Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: a clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia.

Authors: Benjamin Bereznai; Ulrich Steude; Klaus Seelos; Kai Bötzel
Journal: Mov Disord Date: 2002-01 Impact factor: 10.338

10. What are the determinants of quality of life in people with cervical dystonia?

Authors: Y Ben-Shlomo; L Camfield; T Warner
Journal: J Neurol Neurosurg Psychiatry Date: 2002-05 Impact factor: 10.154

29 in total

Review 1. High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors: R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal: J Neural Transm (Vienna) Date: 2010-12-29 Impact factor: 3.575

Review 2. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors: Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853

Review 3. What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?

Authors: Rüdiger Hilker; Angelo Antonini; Per Odin
Journal: J Neural Transm (Vienna) Date: 2010-12-25 Impact factor: 3.575

4. Quality of life in Serbian patients with Parkinson's disease.

Authors: Ljubomir Ziropada; Elka Stefanova; Aleksandra Potrebić; Vladimir S Kostić
Journal: Qual Life Res Date: 2009-06-27 Impact factor: 4.147

5. Suppression of deep brain stimulation artifacts from the electroencephalogram by frequency-domain Hampel filtering.

Authors: David P Allen; Elizabeth L Stegemöller; Cindy Zadikoff; Joshua M Rosenow; Colum D Mackinnon
Journal: Clin Neurophysiol Date: 2010-04-01 Impact factor: 3.708

Review 6. Deep brain stimulation.

Authors: Joel S Perlmutter; Jonathan W Mink
Journal: Annu Rev Neurosci Date: 2006 Impact factor: 12.449